The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer

NCT04185649 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

410

Enrollment

INDUSTRY

Sponsor class

Conditions

HER2-positive Advanced Breast Cancer

Interventions

BIOLOGICAL: BAT8001 for injection
DRUG: Lapatinib
DRUG: Capecitabine

Sponsor

Bio-Thera Solutions